Key result
Single-concentration binding screens require ligand-excess design and end-to-end testing to mitigate hit misclassification.
Why the study?
Single-concentration binding screens are vulnerable to misclassification due to nonadditive compound-target signals and small concentration errors amplifying readout inaccuracies.
Answers are grounded in this paper and cite their sources.
Identifies a fundamental vulnerability in single-concentration binding screens where nonadditive signals can lead to severe hit misclassification, and proposes a practical workflow to mitigate this risk.
High-throughput screening of large compound libraries is central to drug discovery and chemical probe development. Primary screens typically test each compound at a single concentration and classify hits according to whether the measured signal crosses a preset threshold. Only hits advance to multiconcentration assays for binding-isotherm construction and determination of equilibrium dissociation constants, Kd. Incorrect hit calling is usually attributed to chemistry-specific nuisance behavior, platform-dependent artifacts, screening concentration, and threshold selection. Here, we identify an additional fundamental vulnerability in single-concentration binding screens. First-principles analysis shows that when the reported compound-target signal is nonadditive, meaning that the mixture signal cannot be expressed as a weighted sum of free-target and bound-complex signals, small errors in nominal compound and target concentrations can be amplified into large errors in the single-point readout used for hit calling. Nonadditivity can arise from nonlinear signal formation during measurement or nonlinear transformations during postacquisition processing. Controlled end-to-end simulations, in which true Kd values and signal transformations are known, map the operating regimes where this amplification is most severe. The resulting distortions can produce irreversible false negatives because missed binders do not advance to secondary characterization; in some regimes, true high-affinity binders are preferentially penalized. We translate these findings into a practical workflow emphasizing definition of the desired Kd range, ligand-excess design when feasible, concentration control, end-to-end testing of readout additivity and monotonicity, and pilot- or simulation-based assessment of hit-misclassification risk.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied Drug discovery. Single-concentration binding screens was evaluated on Hit misclassification and false negatives. Single-concentration binding screens with nonadditive compound-target signals can amplify small concentration errors into large readout distortions, producing irreversible false negatives.
Synapse has enriched 10 related papers. Consider them for comparative context: